Surviving CGT's Funding Winter In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market By Alun Evans James Strachan July 15, 2026 11 min The Medicine Maker Share Summary Listen Insight Report Quiz Top Institutions